GlassScriptPhysician profile
Thomas Nordquist
NPI 1023470754
$22,568.98
in general payments reported to CMS, 2019-2025
33 companies · $500 in 2025
The $500 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,491 · 2020: $959 · 2021: $1,639 · 2022: $1,214 · 2023: $1,718 · 2024: $10K · 2025: $500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,600 · Food and Beverage: $3,152 · Travel and Lodging: $2,514.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,600.00 |
| Food and Beverage | $3,152.39 |
| Travel and Lodging | $2,513.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $8,241.70 | 2019-2025 | T2 Alpha, Hoffmann, Augment Injectable |
| Merete Technologies, INC | $4,950.00 | 2022-2024 | |
| Fusion Orthopedics USA, LLC | $2,505.61 | 2024 | |
| Sioux Surgical INC | $1,159.85 | 2024 | |
| Zimmer Biomet Holdings, INC. | $1,044.64 | 2019-2021 | |
| Biotissue Holdings INC. | $1,000.64 | 2021-2022 | |
| Kerecis Limited | $453.38 | 2019-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Orthofix Medical, INC. | $327.72 | 2022-2024 | Physio-Stim, Accelstim |
| Acera Surgical, INC. | $294.59 | 2020-2021 | |
| Arthrex, INC. | $262.65 | 2024 | |
| International Life Sciences | $250.00 | 2020 | |
| Linvatec Corporation | $224.91 | 2019 | |
| Amniox Medical, INC. | $191.84 | 2019-2020 | |
| Restor3d, INC. | $176.58 | 2025 | |
| Ortho Solutions INC | $170.00 | 2024 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $162.81 | 2019-2021 | |
| Medline Industries LP | $122.89 | 2019-2020 | |
| Checkpoint Surgical, INC | $114.23 | 2022-2023 | Checkpoint Stimulators |
| Medshape, INC. | $111.78 | 2023 | Dynanail |
| Arthrosurface Incorporated | $110.18 | 2019 | |
| Crossroads Extremity Systems, LLC | $108.10 | 2019 | |
| Smith+Nephew, INC. | $108.06 | 2019-2021 | |
| Paragon 28, INC. | $106.63 | 2019-2022 | |
| Axogen | $67.70 | 2019-2020 | |
| Organogenesis INC. | $67.67 | 2022-2025 | Puraply, Puraply Wound Matrix |
| Treace Medical Concepts, INC. | $59.22 | 2023 | |
| Paratek Pharmaceuticals, INC. | $57.81 | 2023-2024 | Nuzyra |
| Horizon Therapeutics Plc | $25.72 | 2021-2022 | |
| Melinta Therapeutics, LLC | $23.30 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $22.96 | 2025 | |
| Misonix INC | $16.67 | 2021 | |
| Abbott Laboratories | $16.16 | 2021 | |
| Polynovo North America LLC | $12.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Nordquist listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.